Replies to post #191216 on Biotech Values

[DewDiligence]

JAGX -11% despite inking API-supply agreement with Glenmark Pharmaceuticals:

http://finance.yahoo.com/news/jaguar-animal-health-signs-crofelemer-130500543.html

The stock is now trading at less than half its May 2015 IPO price (#msg-113625541).

[DewDiligence]

JAGX +70% on financing with buyout option:

http://finance.yahoo.com/news/jaguar-animal-health-announces-15-103000142.html

Even after today’s pop, the stock is down 2/3 from its IPO about a year ago.